Literature DB >> 23039142

Role of recombination activating genes in the generation of antigen receptor diversity and beyond.

Mayilaadumveettil Nishana1, Sathees C Raghavan.   

Abstract

V(D)J recombination is the process by which antibody and T-cell receptor diversity is attained. During this process, antigen receptor gene segments are cleaved and rejoined by non-homologous DNA end joining for the generation of combinatorial diversity. The major players of the initial process of cleavage are the proteins known as RAG1 (recombination activating gene 1) and RAG2. In this review, we discuss the physiological function of RAGs as a sequence-specific nuclease and its pathological role as a structure-specific nuclease. The first part of the review discusses the basic mechanism of V(D)J recombination, and the last part focuses on how the RAG complex functions as a sequence-specific and structure-specific nuclease. It also deals with the off-target cleavage of RAGs and its implications in genomic instability.
© 2012 The Authors. Immunology © 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23039142      PMCID: PMC3530083          DOI: 10.1111/imm.12009

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  122 in total

Review 1.  Antigen receptor selection by editing or downregulation of V(D)J recombination.

Authors:  David Nemazee; Kristin A Hogquist
Journal:  Curr Opin Immunol       Date:  2003-04       Impact factor: 7.486

Review 2.  RAGs and regulation of autoantibodies.

Authors:  Mila Jankovic; Rafael Casellas; Nikos Yannoutsos; Hedda Wardemann; Michel C Nussenzweig
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

Review 3.  Molecular analysis of V(D)J recombination.

Authors:  M Gellert
Journal:  Annu Rev Genet       Date:  1992       Impact factor: 16.830

4.  Differential reaction kinetics, cleavage complex formation, and nonamer binding domain dependence dictate the structure-specific and sequence-specific nuclease activity of RAGs.

Authors:  Abani Kanta Naik; Sathees C Raghavan
Journal:  J Mol Biol       Date:  2011-11-12       Impact factor: 5.469

5.  A gradient of template dependence defines distinct biological roles for family X polymerases in nonhomologous end joining.

Authors:  Stephanie A Nick McElhinny; Jody M Havener; Miguel Garcia-Diaz; Raquel Juárez; Katarzyna Bebenek; Barbara L Kee; Luis Blanco; Thomas A Kunkel; Dale A Ramsden
Journal:  Mol Cell       Date:  2005-08-05       Impact factor: 17.970

6.  Distinct DNA sequence and structure requirements for the two steps of V(D)J recombination signal cleavage.

Authors:  D A Ramsden; J F McBlane; D C van Gent; M Gellert
Journal:  EMBO J       Date:  1996-06-17       Impact factor: 11.598

7.  RAG1 and RAG2 form a stable postcleavage synaptic complex with DNA containing signal ends in V(D)J recombination.

Authors:  A Agrawal; D G Schatz
Journal:  Cell       Date:  1997-04-04       Impact factor: 41.582

8.  The molecular basis of antibody formation: a paradox.

Authors:  W J Dreyer; J C Bennett
Journal:  Proc Natl Acad Sci U S A       Date:  1965-09       Impact factor: 11.205

9.  The V(D)J recombination activating gene, RAG-1.

Authors:  D G Schatz; M A Oettinger; D Baltimore
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

10.  Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).

Authors:  P Revy; T Muto; Y Levy; F Geissmann; A Plebani; O Sanal; N Catalan; M Forveille; R Dufourcq-Labelouse; A Gennery; I Tezcan; F Ersoy; H Kayserili; A G Ugazio; N Brousse; M Muramatsu; L D Notarangelo; K Kinoshita; T Honjo; A Fischer; A Durandy
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

View more
  20 in total

Review 1.  Novel molecular mechanism for generating NK-cell fitness and memory.

Authors:  Jenny M Karo; Joseph C Sun
Journal:  Eur J Immunol       Date:  2015-06-24       Impact factor: 5.532

Review 2.  Riches in RAGs: Revealing the V(D)J Recombinase through High-Resolution Structures.

Authors:  Karla K Rodgers
Journal:  Trends Biochem Sci       Date:  2016-11-05       Impact factor: 13.807

3.  Preferential Use of Public TCR during Autoimmune Encephalomyelitis.

Authors:  Yunqian Zhao; Phuong Nguyen; Jing Ma; Tianhua Wu; Lindsay L Jones; Deqing Pei; Cheng Cheng; Terrence L Geiger
Journal:  J Immunol       Date:  2016-05-11       Impact factor: 5.422

4.  Differential Chromosomal Localization of Centromeric Histone CENP-A Contributes to Nematode Programmed DNA Elimination.

Authors:  Yuanyuan Kang; Jianbin Wang; Ashley Neff; Stella Kratzer; Hiroshi Kimura; Richard E Davis
Journal:  Cell Rep       Date:  2016-08-18       Impact factor: 9.423

5.  Systematic Profiling of Full-Length Ig and TCR Repertoire Diversity in Rhesus Macaque through Long Read Transcriptome Sequencing.

Authors:  Hayden N Brochu; Elizabeth Tseng; Elise Smith; Matthew J Thomas; Aiden M Jones; Kayleigh R Diveley; Lynn Law; Scott G Hansen; Louis J Picker; Michael Gale; Xinxia Peng
Journal:  J Immunol       Date:  2020-05-06       Impact factor: 5.422

Review 6.  Ubiquitination events that regulate recombination of immunoglobulin Loci gene segments.

Authors:  Jaime Chao; Gerson Rothschild; Uttiya Basu
Journal:  Front Immunol       Date:  2014-03-11       Impact factor: 7.561

Review 7.  AID-induced remodeling of immunoglobulin genes and B cell fate.

Authors:  Brice Laffleur; Nicolas Denis-Lagache; Sophie Péron; Christophe Sirac; Jeanne Moreau; Michel Cogné
Journal:  Oncotarget       Date:  2014-03-15

8.  A Novel Non-Coding Variant in DCLRE1C Results in Deregulated Splicing and Induces SCID Through the Generation of a Truncated ARTEMIS Protein That Fails to Support V(D)J Recombination and DNA Damage Repair.

Authors:  Steven Strubbe; Marieke De Bruyne; Ulrich Pannicke; Elien Beyls; Bart Vandekerckhove; Georges Leclercq; Elfride De Baere; Victoria Bordon; Anne Vral; Klaus Schwarz; Filomeen Haerynck; Tom Taghon
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

Review 9.  Selective Manipulation of the Gut Microbiota Improves Immune Status in Vertebrates.

Authors:  Ana Montalban-Arques; Peter De Schryver; Peter Bossier; Gregor Gorkiewicz; Victoriano Mulero; Delbert Monroe Gatlin; Jorge Galindo-Villegas
Journal:  Front Immunol       Date:  2015-10-09       Impact factor: 7.561

10.  Lipidomic and metabolomic characterization of a genetically modified mouse model of the early stages of human type 1 diabetes pathogenesis.

Authors:  Anne Julie Overgaard; Jacquelyn M Weir; David Peter De Souza; Dedreia Tull; Claus Haase; Peter J Meikle; Flemming Pociot
Journal:  Metabolomics       Date:  2015-11-17       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.